Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Colon O-glycosylated mucus in the homeostasis of microbiota and host
Propranolol in angina pectoris: comparison of therapy given two and four times daily.
Peptide Elongation Factor Tu
Amacrine Cells
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study. Thromb Haemost. 2014 Sep 02; 112(3):445-58.
View in:
PubMed
subject areas
Adolescent
Adult
Antibodies, Blocking
Antibodies, Monoclonal, Murine-Derived
Antibody Formation
Antigens, CD20
Blood Coagulation
Child
Child, Preschool
Factor VIII
Follow-Up Studies
Hemophilia A
Humans
Immunosuppressive Agents
Male
Rituximab
Treatment Outcome
United States
Young Adult